在通过皮肤进行肝脏化学和干预后,高剂量肝素给药后,原氨酸逆转对凝血参数的影响
Michael Metze1, Silke Zimmermann2, Holger Kirsten3
1Center of Hemostaseology, Department of Cardiology, University Hospital Leipzig, Liebigstr. 20, 04103 Leipzig, Germany.
Clinics and practice
|February 25, 2025
概括
在肝脏化学和后给予前胺有效地使aPTT和INR等凝血参数正常化. 剂量影响了结果,较高的蛋白质胺降低了aPTT并增加了纤维素原.
科学领域:
- 干预性放射学 干预性放射学
- 肝胆道手术 肝胆道手术
- 药理学 药理学是指药理学的学科.
背景情况:
- 通过皮肤进行肝脏化学和后,用质氨酸逆转肝素是标准的.
- 质氨酸对凝血后过程的确切影响需要进一步澄清.
研究的目的:
- 为了评估protamine在逆转高剂量肝素的有效性.
- 分析胺对化学和后关键凝血参数的影响.
主要方法:
- 对31名接受90次化学和干预的患者进行了回顾性观察性研究.
- 激活的部分血小板质量时间 (aPTT),国际正常化比率 (INR),原血时间 (PT),纤维素原,血小板数量 (PLT) 和血红蛋白 (Hb) 的分析.
- 线性混合效应模型用于计算每个患者的多种治疗.
主要成果:
- 蛋白质胺使用与较低的aPTT和INR以及较高的PT和纤维素因子有关.
- 血小板和血红蛋白水平在不考虑蛋白质胺使用的情况下仍然可比.
- 观察到剂量依赖的效应:较高的蛋白质胺剂量降低了aPTT并增加了纤维素原.
结论:
- 质氨酸有助于在化学和后使aPTT,INR,PT和纤维素素水平正常化.
- 最佳的前胺剂量策略需要在前性研究中进行调查.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
593
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
593
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.1K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.1K
Depolarizing Blockers: Pharmocokinetics
301
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
301
Hepatic Drug Clearance: Effect of Protein Binding
134
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
134
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
70
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
70


